Custom Search

News

Friday 01 November 2002

Treatment of tendopathies with tropisetron.

By: Stratz T, Varga B, Muller W.

Rheumatol Int 2002 Nov;22(6):219-21

A comparison between a local anesthetic drug and the 5-hydroxytryptamine 3 (5-HT3) receptor antagonist tropisetron in treating tendopathies or periarthropathies revealed that tropisetron has a longer effect on resting pain and pain on movement than the local anesthetic drug. The most likely explanation for this effect probably is a blocking of stimulated 5-HT3 receptors at the nociceptors in conjunction with an inhibited release of substance P and other neurokines because of this blockage. Further studies will have to show whether the action of tropisetron in tendopathies is as favorable as that of corticosteroids.

Use of this site is subject to the following terms of use